AXGN FY 2024 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$187M+17.8% YoY

Gross Profit

$142M75.8% margin

Operating Income

-$3M-1.8% margin

Net Income

-$10M-5.3% margin

EPS (Diluted)

$-0.23

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$11,000

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$204M

Total Liabilities

$100M

Stockholders' Equity

$104M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$187M	$159M	+17.8%
Gross Profit	$142M	$122M	+16.5%
Operating Income	-$3M	-$21M	+84.7%
Net Income	-$10M	-$22M	+54.1%